Skip to content
Sign inOpen the app
Pharmaceutical Executive

Pharmaceutical Executive Daily: Source Denies AstraZeneca-Bristol Myers Squibb Merger Talks

Wednesday · 3 min · 3.3 MB
0:00-3:30

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

Open in podnod

In today's Pharmaceutical Executive Daily, a senior source denies reports of merger talks between AstraZeneca and Bristol Myers Squibb, CSPC Pharmaceutical and AstraZeneca form a joint venture for biologics manufacturing in China, and a feature examines how U.S. Patent and Trademark Office policy changes are slowing patent challenges for generic and biosimilar drugmakers.